PharmaNest, a leader in high resolution, single-fiber, quantitative Digital Pathology and Artificial Intelligence, showcases the utility and performance of its FibroNest Ph-FCS continuous fibrosis biomarker for the quantification of the severity of fibrosis and prognostics of liver related clinical events in NASH.

Nathan Diers promoted to Vice President of Product Development

"Anemia: Influence of Dietary Fat, Sugar, and Salt on Hemoglobin and Blood Health" in an Academic Text for Researchers, Clinicians, Teachers, and Students In Advanced Studies.

EyeKor, Inc. Ranked Number 299 Fastest-Growing Company in North America on Deloitte's 2019 Technology Fast 500™

- A Patented Disruptive Technological Breakthrough in Nutritional Support for The Brain.

Enzymes are essential for all metabolic transactions and N-SORB™, Prodosomed® and metabolically activated enzymes support human health at the recommended dose

EyeKor, Inc., a leading imaging and data management company for the ophthalmic pharmaceutical clinical trial and ocular preclinical laboratory industries, announced today that it is opening a new office in China to enhance EyeKor's capability to provide local support for clinical trial sponsors and sites in China and the APAC region.

Achieve Clinical Research, a privately owned research facility, announces the launch of several research studies to test investigational treatment options for those already diagnosed with Gastroesophageal Reflux Disease or GERD.

Achieve Clinical Research, a privately owned research facility, announces the launch of several research studies to test investigational treatment options for those already diagnosed with rheumatoid arthritis.

Florida Clinical Research Center, LLC (FLCRC) relocated its offices, effective June 3, 2011, to 8043 Cooper Creek Boulevard, Suite 107 in Bradenton, Florida 34201 to accommodate its growing staff and increasing number of clinical studies.

Concepts in Pharmaceutical Research, Inc has launched Clinical Trials for You Division!